Review Series on Basic/Translational Science of Factor VIII, Factor IX, and von Willebrand Factor - Blood Podcast | Lyssna här | Poddtoppen.se
Fler avsnitt av Review Series on Basic/Translational Science of Factor VIII, Factor IX, and von Willebrand Factor
Time-limited triplet therapy in relapsed/refractory CLL; patient-reported outcomes in chronic GVHD-related sclerosis; myeloid bias mechanisms in hematopoiesis
2025-03-20 |
19 min
+
Azacitidine plus venetoclax in high-risk myelodysplastic syndromes, post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia (B-ALL), and inotuzumab ozogamicin resistance in B-ALL
2025-03-13 |
21 min
+
Mutations in AMBRA1 aggravate β-thalassemia; targeting MYD88 mutations in lymphomas; air pollution and incident VTE risk
2025-03-06 |
17 min
+
Hypercalcemia in monoclonal gammopathy of undetermined significance, neutrophil gelatinase-associated lipocalin in hemostasis, and CD19-targeted NK- or T-cell therapy combined with anti-CD19 monoclonal antibodies
2025-02-27 |
19 min
+
Review Series on a Quarter Century of TKIs in CML
2025-02-27 |
33 min
+
A “belt and suspenders” approach to PNH; oral pathogens exacerbate chronic GVHD; microbial metabolome changes may adversely impact CAR-T outcomes
2025-02-21 |
19 min
+
Mosunetuzumab in relapsed/refractory follicular lymphoma, CD70 CAR T-cells and an anti-CD33/anti-CD3 bispecific antibody in acute myeloid leukemia, and ferroptosis in stored red blood cells
2025-02-13 |
23 min
+
Review Series on Basic/Translational Science of Factor VIII, Factor IX, and von Willebrand Factor
2025-02-13 |
31 min
+
Dual TKI targeting in Ph+ ALL; role of liver endothelial ferroportin in iron sensing and homeostasis; severe anemia in pregnant patients with beta-thalassemia minor
2025-02-06 |
18 min
+
First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia
2025-01-30 |
20 min
+
Podden och tillhörande omslagsbild på den här sidan tillhör
American Society of Hematology. Innehållet i podden är skapat av American Society of Hematology och inte av,
eller tillsammans med, Poddtoppen.
En ny version av sidan finns tillgänglig.
Ladda om
Stäng
